IMEMR Current Contents Fax: +20 2 22765424 September 2016 E-Mail: [email protected] Vol
Total Page:16
File Type:pdf, Size:1020Kb
ISSN: 2071-2510 Vol. 11 No.2 For further information contact: World Health Organization Regional Office for the Eastern Mediterranean Knowledge Sharing and Production (KSP) Index Medicus for the Eastern Mediterranean Region (IMEMR) Monazamet El Seha El Alamia Street Extension of Abdel Razak El Sanhouri Street P.O. Box 7608, Nasr City Cairo 11371, Egypt Tel: +20 2 22765047 IMEMR Current Contents Fax: +20 2 22765424 September 2016 e-mail: [email protected] Vol. 15 No. 3 Providing Access to Health Knowledge to Build a Healthy Future http://www.emro.who.int/information-resources/imemr/imemr.html Index Medicus for the WHO Eastern Mediterranean Region with Abstracts IMEMR Current Contents September 2016 Vol. 15 No. 3 © World Health Organization 2016 All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate borderlines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. Publications of the World Health Organization can be obtained from Health Publications, Production and Dissemination, World Health Organization, Regional Office for the Eastern Mediterranean, P.O. Box 7608, Nasr City, Cairo 11371, Egypt (tel: + 202 2276 043, fax: +202 22765 424; email: [email protected]). Requests for permission to reproduce, in part or in whole, or to translate publications of WHO Regional Office for the Eastern Mediterranean – whether for sale or for noncommercial distribution – should be addressed to Regional Adviser, Global Arabic Programme, WHO Regional Office for the Eastern Mediterranean, at the following address: email: [email protected]. Design, layout and printing by WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt ISSN: 2071-2510 Table of Contents IMEMR Current Contents .............................................................................................................. vii Subject Index ................................................................................................................................. ix Acne Vulgaris .............................................................................................................................. 1 Aloe ............................................................................................................................................ 1 Alopecia Areata .......................................................................................................................... 2 Amino Acid Metabolism, Inborn Errors ...................................................................................... 2 Anemia, Aplastic ......................................................................................................................... 3 Anemia, Iron‐Deficiency ............................................................................................................. 3 Ankle Injuries .............................................................................................................................. 4 Anti‐Bacterial Agents .................................................................................................................. 4 Antibiotic Prophylaxis ................................................................................................................. 5 Antiprotozoal Agents .................................................................................................................. 5 Appendicitis ................................................................................................................................ 6 Arbutin ....................................................................................................................................... 6 Arterial Occlusive Diseases ......................................................................................................... 7 Arthritis, Juvenile........................................................................................................................ 7 Arthritis, Rheumatoid ................................................................................................................. 8 Arthroplasty, Replacement, Knee .............................................................................................. 8 Asthma ....................................................................................................................................... 8 Astigmatism ................................................................................................................................ 9 Atorvastatin Calcium ................................................................................................................ 10 Autoexperimentation ............................................................................................................... 10 Bariatric Surgery ....................................................................................................................... 10 Behcet Syndrome ..................................................................................................................... 11 Benzhydryl Compounds ............................................................................................................ 11 beta‐Thalassemia ..................................................................................................................... 12 Blepharophimosis ..................................................................................................................... 13 Blepharoptosis ......................................................................................................................... 13 Body Dysmorphic Disorders ..................................................................................................... 13 Books ........................................................................................................................................ 14 Breast Neoplasms ..................................................................................................................... 15 Bronchiolitis ............................................................................................................................. 16 Calcitonin.................................................................................................................................. 16 Camellia sinensis ...................................................................................................................... 17 Canaliculitis .............................................................................................................................. 17 Candidiasis................................................................................................................................ 18 Capparis .................................................................................................................................... 18 Carbamazepine......................................................................................................................... 18 Carbon Dioxide ......................................................................................................................... 19 Carbon Tetrachloride ............................................................................................................... 20 Carcinoma, Basal Cell ............................................................................................................... 20 Carcinoma, Hepatocellular ....................................................................................................... 21 Cardiovascular Diseases ........................................................................................................... 21 Cataract .................................................................................................................................... 21 Central Serous Chorioretinopathy ............................................................................................ 22 i Central Venous Catheters ........................................................................................................ 22 Cephalometry ........................................................................................................................... 23 Cerebellar Diseases .................................................................................................................. 23 Cholecystectomy, Laparoscopic ............................................................................................... 23 Cholesteatoma ........................................................................................................................